Glycoprotein Receptor Antagonist Patency Evaluation - GRAPE

Description:

Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) was a pilot study to evaluate the effect of a strategy of “upstream” or early abciximab administered prior to primary percutaneous coronary intervention (PCI) for acute myocardial infarction (MI) on patency of the infarct-related artery, as determined by initial diagnostic angiography.